UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of the endocrine-disrupting potential of halogenated parabens: An in silico approach

Chemosphere (Oxford), 2021-02, Vol.264 (Pt 1), p.128447, Article 128447

Jakopin, Žiga

2021

Volltextzugriff (PDF)

2-aminothiazoles in drug discovery: Privileged structures or toxicophores?

Chemico-biological interactions, 2020-10, Vol.330, p.109244-109244, Article 109244

Jakopin, Žiga

2020

Volltextzugriff (PDF)

Ethyl 5-trichloromethyl-1,2,4-oxadiazole-3-carboxylate as a versatile building block in medicinal chemistry

Tetrahedron letters, 2018-12, Vol.59 (49), p.4320-4322

Jakopin, Žiga

2018

Volltextzugriff (PDF)

Nucleotide-Binding Oligomerization Domain (NOD) Inhibitors: A Rational Approach toward Inhibition of NOD Signaling Pathway

Journal of medicinal chemistry, 2014-08, Vol.57 (16), p.6897-6918

Jakopin, Žiga

2014

Volltextzugriff (PDF)

In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products

Food and chemical toxicology, 2023-03, Vol.173, p.113623-113623, Article 113623

2023

Volltextzugriff (PDF)

Structural features of subtype-selective EP receptor modulators

Drug discovery today, 2017-01, Vol.22 (1), p.57-71

2017

Volltextzugriff (PDF)

Synthesis of Conformationally Constrained d-Glu- meso -DAP Analogs as Innate Immune Agonists

Molecules (Basel, Switzerland), 2020-11, Vol.25 (22), p.5228

2020

Volltextzugriff (PDF)

THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists

International journal of molecular sciences, 2019-08, Vol.20 (17), p.4265

2019

Volltextzugriff (PDF)

Risks associated with fat burners: A toxicological perspective

Food and chemical toxicology, 2019-01, Vol.123, p.205-224

Jakopin, Žiga

2019

Volltextzugriff (PDF)

Halogenated ingredients of household and personal care products as emerging endocrine disruptors

Chemosphere (Oxford), 2022-09, Vol.303 (Pt 1), p.134824-134824, Article 134824

2022

Volltextzugriff (PDF)

The design and synthesis of Ala-Glu/iGln mimetics: heterocyclic building blocks for pseudopeptides

Tetrahedron letters, 2015-01, Vol.56 (3), p.504-506

Jakopin, Ziga

2015

Volltextzugriff (PDF)

Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells

Frontiers in pharmacology, 2022-07, Vol.13, p.920928-920928

2022

Volltextzugriff (PDF)

In vitro investigation of immunomodulatory activities of selected UV-filters

Food and chemical toxicology, 2023-04, Vol.174, p.113684-113684, Article 113684

2023

Volltextzugriff (PDF)

Murabutide revisited: a review of its pleiotropic biological effects

Current medicinal chemistry, 2013-05, Vol.20 (16), p.2068-2079

Jakopin, Ziga

2013

Volltextzugriff (PDF)

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency

ACS medicinal chemistry letters, 2022-08, Vol.13 (8), p.1270-1277

2022

Volltextzugriff (PDF)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

Journal of medicinal chemistry, 2022-11, Vol.65 (22), p.15085-15101

2022

Volltextzugriff (PDF)

Environmental contamination status with common ingredients of household and personal care products exhibiting endocrine-disrupting potential

Environmental science and pollution research international, 2022-10, Vol.29 (49), p.73648-73674

2022

Volltextzugriff (PDF)

Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity

European journal of medicinal chemistry, 2017-07, Vol.135, p.491-516

2017

Volltextzugriff (PDF)

Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties

Journal of medicinal chemistry, 2018-04, Vol.61 (7), p.2707-2724

2018

Volltextzugriff (PDF)

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists

Journal of medicinal chemistry, 2024-02, Vol.67 (4), p.3004-3017

2024

Volltextzugriff (PDF)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

Journal of medicinal chemistry, 2021-06, Vol.64 (11), p.7809-7838

2021

Volltextzugriff (PDF)

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy

Medicinal research reviews, 2019-09, Vol.39 (5), p.1447-1484

2019

Volltextzugriff (PDF)

Galectin-8N-Selective 4‑Halophenylphthalazinone-Galactals Double π‑Stack in a Unique Pocket

ACS medicinal chemistry letters, 2024-08, Vol.15 (8), p.1319-1324

2024

Volltextzugriff (PDF)

GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI

Biochemical pharmacology, 2021-01, Vol.183, p.114315-114315, Article 114315

2021

Volltextzugriff (PDF)

Iron-Binding and Anti-Fenton Properties of Novel Amino Acid-Derived Cyclic Imide Dioximes

Antioxidants, 2019-10, Vol.8 (10), p.473

2019

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(50)
Pharmacology & Pharmacy
(37)
Chemistry, Medicinal
(29)
Humans
(26)
Chemistry
(12)
Physical Sciences
(12)
Biochemistry & Molecular Biology
(11)
Drug Design
(10)
Chemistry, Organic
(9)
Ligands
(8)
Structure-Activity Relationship
(8)
Molecular Structure
(7)
Nod2 Signaling Adaptor Protein - Metabolism
(7)
Animals
(6)
Dose-Response Relationship, Drug
(6)
Immunomodulation
(6)
1,2,4-Oxadiazole
(5)
Basic Medicine
(5)
Immunostimulant
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Assessment of the endocrine-disrupting potential of halogenated parabens: An in silico approach

2-aminothiazoles in drug discovery: Privileged structures or toxicophores?

Ethyl 5-trichloromethyl-1,2,4-oxadiazole-3-carboxylate as a versatile building block in medicinal chemistry

Nucleotide-Binding Oligomerization Domain (NOD) Inhibitors: A Rational Approach toward Inhibition of NOD Signaling Pathway

In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products

Structural features of subtype-selective EP receptor modulators

Synthesis of Conformationally Constrained d-Glu- meso -DAP Analogs as Innate Immune Agonists

THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists

Risks associated with fat burners: A toxicological perspective

Halogenated ingredients of household and personal care products as emerging endocrine disruptors

The design and synthesis of Ala-Glu/iGln mimetics: heterocyclic building blocks for pseudopeptides

Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells

In vitro investigation of immunomodulatory activities of selected UV-filters

Murabutide revisited: a review of its pleiotropic biological effects

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

Environmental contamination status with common ingredients of household and personal care products exhibiting endocrine-disrupting potential

Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity

Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy

Galectin-8N-Selective 4‑Halophenylphthalazinone-Galactals Double π‑Stack in a Unique Pocket

GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI

Iron-Binding and Anti-Fenton Properties of Novel Amino Acid-Derived Cyclic Imide Dioximes

Suchergebnisse filtern